Recordati Industria Chimica e Farmaceutica S.p.A. Financials

Market Capitalization €11.03 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	26.70
Forward PE	19.28
Price to Sales TTM	€4.57
Price to Book MRQ	€5.57
Enterprise to Revenue	5.41
Enterprise to EBITDA	15.06

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	17.32%
Operating Margin	28.94%
Return on Assets TTM	9.33%
Return on Equity TTM	22.03%

Income Statement

Revenue TTM	€2,413,699,072
Revenue per Share TTM	€11.70
Quarterly Revenue Growth	11.90%
Gross Profit TTM	€1,680,994,944
EBITDA	€841,928,000
Net Income to Common TTM	€417,953,984
Diluted EPS TTM	€2.00
Quarterly Earnings Growth YoY	1.20%

Balance Sheet

Total Cash MRQ	€333,044,000
Total Cash per Share MRQ	€1.61
Total Debt MRQ	€
Total Debt to Equity MRQ	119.56
Current Ratio MRQ	1.59
Book Value per Share MRQ	€9.58

Cash Flow

Operating Cash Flow TTM	€583,662,016
Levered Free Cash Flow TTM	€-356,248,736

REC Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	206,296,235
Float Shares	100,360,912
Avg 10 Volume	238,664
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	46.82%
% Held by Institutions	28.78%

Stock Price Summary

Beta	0.52
Fifty Two Week Low	€43.98
Fifty Two Week High	€60.95
Fifty Two Week Change	9.08%
Day 50 MA	€52.50
Day 200 MA	€52.74

Dividends and Splits

Forward Annual Dividend Rate	€1.20
Forward Annual Dividend Yield	2.22%
Trailing Annual Dividend Rate	€1.23
Trailing Annual Dividend Yield	2.28%
Payout Ratio	61.53%
Dividend Date
Ex Dividend Date	2025-05-19
Last Split Factor
Last Split Date	2005-04-18